Wednesday’s analyst upgrades and downgrades

Dollarama shares fell nearly 10% after Q4 results; Desjardins cut its price target to C$205 from C$218 while increasing Australia loss estimates to ~C$70m (from C$24m) including A$35–45m of incremental integration costs, but still estimates ~4% 4Q SSSG and sees 1Q-to-date tracking above management's 3–4% guide. Other analysts trimmed targets (National Bank C$198 from C$225; Canaccord C$187 from C$207) while largely maintaining buy/outperform views, framing FY27 as an investment year for international expansion. RBC's Darko Mihelic trimmed price targets across major Canadian banks (BMO C$205, CIBC C$147, NA C$180, BNS C$98, TD C$138) citing high sector forward P/E (13.0x vs historical 10.8x). National Bank initiated Anaergia at C$5 with an "outperform" rating, highlighting a capital-light, policy-driven renewable-growth thesis.

Analysis

The recent market reaction creates a tactical entry for the core Canadian variety-store play: short-term headline noise has pushed the equity to price in a materially worse execution scenario than appears likely, while the company retains a capital-stable profile to underwrite a multi-year expansion. The key operational lever to watch is SKU-level margin mix during the rollout: if management maintains value perception while migrating assortments, gross-margin dilution should be temporary and offset by higher LFL unit economics within 2-4 quarters.

For Canadian banks, valuations are sitting in a narrow band that is vulnerable to a modest deterioration in credit or a re-rating of private-credit exposure; the next 6-12 months are the highest-probability window for multiple compression if macro momentum fades. Second-order risks include deposit flight into private credit vehicles and concentrated CRE/energy exposures that show up unevenly across issuers, meaning active selection matters more than broad index positioning.

The renewable waste-to-value specialist presents a structural growth call driven by policy visibility and an improving recurring-revenue mix; execution risk is now more about backlog conversion cadence than technology validation. This makes a multi-year long with a staged size-up attractive, and also creates M&A optionality that could re-price the cap structure if a strategic buyer emerges within 12-36 months.

Key Decisions for Investors

• Buy DOL.TO equity (weight 1.0–1.5% of portfolio). Target +20% over 12 months, stop-loss at -10%. Hedge macro risk by pairing with a 0.5% short position in a Canadian retail basket or short BNS to reduce correlation to domestic consumption shocks.
• Initiate a long ANRG.TO position (weight 0.5–1.0%) with a staged add on 25–50% backlog-conversion beats. Time horizon 18–36 months; target +60%+, stop-loss at -30%. Consider Jan-2028 LEAP calls (if implied vol and liquidity permit) for asymmetric upside while capping cash outlay.
• Reduce/avoid overweight positions in large Canadian banks; if exposure is required, buy 12-month out-of-the-money puts on BMO or CM (~5–7% OTM) as insurance against a 15–25% drawdown in the sector. If conviction on credit stress increases, switch to a short-ETF or sell 1–2% of holdings in the next 3 months.
• Pair trade for lower beta: long DOL.TO / short equal-dollar basket of BMO+CM (0.5% each). This isolates execution-on-expansion vs. macro/credit risk and targets a positive carry if DOL re-rating occurs while banks re-price lower; close within 6–12 months or on a 15% move in either leg.